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Abstract
According to the EP monograph “Sodium hyaluronate” for identification they use the infrared transmission spectrum of 
the substance, quantification is carried out by spectrophotometry.
The aim of the work was to develop a method for quantitative determination of hyaluronic acid in the gel in the presence 
of other substances and its validation.
Materials and Methods. The object of the study were samples of combined dental gel of the following composition: 
metronidazole benzoate 16 mg/g, miramistin 5 mg/g, sodium hyaluronate 2 mg/g. Identification and quantification of sodium hy-
aluronate was performed by liquid chromatography (SPhU, 2.2.29, 2.2.46). The test solution and the reference solution were chro-
matographed, obtaining the number of parallel chromatograms not less than when checking the suitability of the chromatographic 
system. Chromatography is performed on a liquid chromatograph with a diode-matrix detector under the following conditions: 
chromatographic column PL-aquagel-OH, Agilent size 300×7.5 mm, with a particle size of sorbent 8 μm; mobile phase A: 0.1 M 
sodium sulfate solution; mobile phase B: acetonitrile for chromatography P; detection at a wavelength of 210 nm.
Results. The retention time of sodium hyaluronate on the chromatogram of the test sample of the gel coincides with the 
peak and the retention time on the chromatogram of the comparison solution of the standard sample of the substance. The suit-
ability of the chromatographic system for 3 parallel determinations was checked: the relative standard deviation (RSD) is equal 
to 0.25, the number of theoretical plates is 980, the symmetry coefficient is 1.293. The validation characteristics of the developed 
methodology meet the established eligibility criteria. The spectral purity coefficients (Fp) of the sodium hyaluronate peak on the 
chromatograms of the model solution are Fp1=997.665 and Fp2=997,802. The method is linear in the range of sodium concentra-
tion of hyaluronate 80–120 %, the calculated linear dependence of the reduced area of the chromatographic peak on the reduced 
concentration of sodium hyaluronate is |a|=1.9490≤Δa=2.56. The confidence interval of the unit value for the sample of relations 
is found/entered Δz=1.08, which corresponds to the condition Δz≤1.6 %. The value of the systematic error is equal to δ=0.12, 
which satisfies the condition δ≤0.51 %.
Conclusions. The method of quantitative determination of sodium hyaluronate by the method of high-performance liquid 
chromatography has been developed and investigated. The method allows the identification and quantification of sodium hyal-
uronate in the composition of the dental gel, in the presence of metronidazole benzoate and miramistin. Validation of the meth-
odology was performed and the main validation characteristics were determined. In terms of specificity, linearity, correctness, 
convergence of the method meets the eligibility criteria established by the SPhU.
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1. Introduction
Hyaluronic acid (HA) is a key element in the soft tissues of the periodontium and periodon-
tal ligament, as well as in hard tissue such as alveolar bone, and performs many structural and 
physiological functions in these tissues [1].
Today HA is widely used in many branches of medicine with interesting potential applica-
tions in dentistry for the treatment of acute and chronic inflammatory disease. Data obtained from 
the present review of 20 clinical studies demonstrate that, due to its positive action on tissue repair 
and wound healing, topical administration of HA could play a role not only in postoperative dental 
surgery, but also in the treatment of patients affected by gingivitis and periodontitis, with a signif-
icant improvement in their quality of life [2, 3].
Hyaluronic acid is used as a single drug in the form of solutions, gels, injectable solutions, or 
in combination with antibacterial, antiseptic active pharmaceutical ingredients, vitamins, etc. [4–7].
The object of our research is a combined dental gel that contains hyaluronic acid and two 
active substances with antibacterial action: metronidazole and miramistin. Hyaluronic acid is a 
natural unsulfated glycosaminoglycan with a high molecular weight of 4000–20000000 [1]. Iden-
tification of hyaluronic acid as an active pharmaceutical ingredient (API) is carried out by various 
physicochemical methods. The simplest method is infrared spectroscopy using Fourier transform, 
also using high-resolution nuclear magnetic resonance spectroscopy [8]. The acidic properties of 
hyaluronate allow to obtain solutions in water of salts with alkali metals. Hyaluronic acid is an 
anionic linear polysaccharide with different molecular weight, which depends on the method of 
its production. The absence of isomerism, which is characteristic of most glucosaminoglycans, 
ensures the chemical identity of the obtained hyaluronates [9].
According to the monograph of the European Pharmacopoeia “Sodium hyaluronate”, the in-
frared transmission spectrum of the substance is used for identification, which should be identical 
to the spectrum of the standard sample. Quantitative determination is performed by spectropho-
tometry using carbazole reagent, measuring the optical density at a wavelength of 530 nm [10, 11]. 
In addition to sodium hyaluronate, the developed gel contains metronidazole benzoate and mira-
mistin. Our studies have shown that the method of absorption spectrophotometry does not allow 
a reliable quantitative assessment of the content of hyaluronic acid in the presence of other com-
ponents of the drug, in particular metronidazole benzoate [12]. High-performance liquid chroma-
tography (HPLC) is used to quantify hyaluronic acid or its decomposition products. This method 
allows the determination of hyaluronic acid in both biological fluids and in the composition of 
combined drugs. The HPLC method is characterized by high specificity and allows to level obsta-
cles from excipients [13, 14].
The aim of the work was to develop an analytical method for the quantitative determination 
of hyaluronic acid in the gel in the presence of other substances and its validation.
2. Materials and methods
The object of the study were samples of combined dental gel of the following composition: 
metronidazole benzoate 16 mg/g, miramistin 5 mg/g, sodium hyaluronate 2 mg/g. Hyaluronic 
acid in the form of sodium hyaluronate manufactured by Shiseido Co., LtD, Japan was used to 
make the gel.
The tests are performed by liquid chromatography (SPhU, 2.2.29, 2.2.46) [15].
Test solution. Place about 1000.0 mg (exact amount) of the gel in a 25.0 ml volumetric flask, 
make up to volume with the mobile phase, close tightly with a lid and shake vigorously to dissolve 
the gel. The solution is transferred to a centrifuge tube and centrifuged for 15 min at 10,000 rpm. 
The supernatant is filtered through a membrane fluoroplastic filter with a pore size of 0.45 μm, 
discarding the first 0.5 ml of filtrate.
Comparison solution. About 40.0 mg (exact amount) of sodium hyaluronate (PRS SPhU), 
pre-dried over phosphorus (v) oxide P in a vacuum oven (residual pressure 0.67 kPa) at a tempera-
ture of 60 ºC for 5 hours, is placed in a volumetric flask with a capacity of 100.0 ml, add 60 ml of 
water P, maintain in an ultrasonic bath until the sample is dissolved, bring the volume of the solu-
tion with the same solvent to the mark and mix.
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Place 10.0 ml of the resulting solution in a 50.0 ml volumetric flask, make up to volume with 
the mobile phase and mix.
Chromatograph the reference solution to get from 2 to 4 chromatograms. For the areas of the 
sodium hyaluronate peak from the obtained chromatograms of the comparison solution, the relative 
standard deviation (RSD) is calculated. Obtaining parallel chromatograms (n0) is stopped when the 
requirements set by SPhU to the RSD (SPhU, 2.2.46) are reached.
Chromatograph the test solution and the reference solution, obtaining the number of 
parallel chromatograms (n) not less than when checking the suitability of the chromatographic 
system (n0).
Chromatography is performed on a liquid chromatograph with a diode-matrix detector un-
der the following conditions:
– chromatographic column PL-aquagel-OH, Agilent size 300 mm×7.5 mm, with a particle 
size of sorbent 8 μm, or similar, for which the requirements of the test “Checking the suitability of 
the chromatographic system” are met;
– mobile phase A: 0.1 M sodium sulfate solution;
– mobile phase B: acetonitrile for chromatography P;
– detection by wavelength: 210nm;
– mobile flow rate – 1.0 ml/min;
– injection volume – 50 μl;
– column thermostat temperature – 40 ºС.
Chromatography is performed according to the gradient program shown in Table 1.
Table 1
Characteristics of the gradient program for chromatography
Time (min) Mobile phase A (%, v/v) Mobile phase В (%, v/v) Notes
0 – 2 100 0 Isocratic mode
2 – 3 100→90 0→10 Linear gradient
3 – 30 90 10 Isocratic mode
30 – 31 90→100 10→0 Linear gradient
31 – 40 100 0 Isocratic mode
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where Si – the average value of the peak areas of sodium hyaluronate, calculated from the chro-
matograms of the test solution; S0 – the average value of the peak areas of sodium hyaluronate, 
calculated from the chromatograms of the comparison solution; m0 – weight of a sample of a stan-
dard sample of sodium hyaluronate, in milligrams; mі – weight of the drug sample, in milligrams; 
Р – the content of the basic substance in the standard sample of sodium hyaluronate in terms of dry 
matter, as a percentage.
The content of sodium hyaluronate in 1 g of the drug should be from 1.90 mg to 2.1 mg at 
the time of release and during storage.
3. Results
The chromatograms of the test solution and the standard sample of sodium hyaluronate 
solution are shown in Fig. 1, 2.
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Fig. 1. Chromatogram of a standard sample solution of sodium hyaluronate.
Fig. 2. Chromatogram of test gel solution for identification and quantification of sodium 
hyaluronate
Relative standard deviation (RSD) is calculated for the areas of sodium hyaluronate peak. 
Also evaluate the efficiency of the chromatographic column at the peak of sodium hyaluronate and 
the symmetry coefficient of sodium hyaluronate.
Checking the suitability of the chromatographic system has the following eligibility 
criteria:
– the relative standard deviation (RSD) of the areas of the sodium hyaluronate peaks ob-
tained from the chromatograms of the reference solution must meet the requirements of SPhU, 
2.2.46 according to the number of parallel injections (Table 2);
– the number of theoretical plates calculated from the chromatograms of the comparison 
solution at the peak of sodium hyaluronate must be at least 500;
– the symmetry coefficient of the peak of sodium hyaluronate calculated from the chro-
matograms of the reference solution should not exceed 2.5;
The results are shown in Table 3, confirm that the requirements for the suitability of the 
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Table 2
Eligibility criteria for relative standard deviation
Indicator
Number of parallel injections
2 3 4 5 6
RSD, % <0.25 <0.67 <0.96 <1.19 <1.38
Table 3
The results of checking the suitability of the chromatographic system
ni Peak area (Si)
RSD, % Column efficiency, number of theoretical plates Symmetry coefficient
Calculated Requirements Calculated Requirements Calculated Requirements




2 245.327 0.14 <0.25 973 1.277
3 244.127 0.25 <0.67 980 1.293
4 – – <0.96 – –
5 – – <1.19 – –
6 – – <1.38 – –
The study of validation characteristics of the method of quantitative determination of sodi-
um hyaluronate concerned the following characteristics:
– control of specificity of a technique;
– control of linearity of a technique;
– control of the correctness of the methodology;
– control of convergence of methods.
Criteria of acceptability at control of specificity of a technique:
– on the chromatograms of the placebo solution there should be no peaks with retention time 
in the ranges for sodium hyaluronate;
– the coefficient of spectral purity of the peak of sodium hyaluronate must be at least 995 
( )995.0 .≥pF
The chromatograms of the reference solution and the chromatograms of the placebo solu-
tion are compared. The chromatogram of the reference solution for the sodium hyaluronate peak 
determines the retention times (tRi), the width of the peaks (wi) and the ranges (tRi±wi). The research 
results are shown in Table 4.
Table 4
The results of studying the specificity of the method of quantitative determination
Chromatograms 1 2







Combined range tRi±wi 3.828–6.137
The presence of placebo 
peaks with a retention 
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The spectral purity (Fp) coefficients of the sodium hyaluronate peak calculated by 
the software complex of the rare chromatograph on the chromatograms of the model solu-
tion are Fp1=997.665 and Fp2=997.802. The obtained values meet the acceptability criterion 
Fp≥995.0.
The specificity of the method of quantitative determination of sodium hyaluronate is con-
firmed by the fact that the chromatograms of placebo solution there are no peaks with a retention 
time in the range tRi±wi for the analyte, therefore, placebo components do not affect the results 
obtained by the study method. The coefficients of the spectral purity of the analyte peak meet the 
criterion of acceptability and the studied technique has sufficient specificity.
Criteria of acceptability of control of linearity of a technique:
For the linear dependence of the given area of the chromatographic peak on the given con-
centration of the analyte content:
– the free member of the linear dependence must not exceed its confidence interval: 
|a|≤2.56 %;
– linear correlation coefficient: Rс≥minRc.
The results of determining the linearity of the technique are shown in Table 5.
Table 5
The results of determining the linearity of the method
No. The content of the analyte, % Si iS Xi, % Yi, %
1 80 197.124; 196.517 196.821 80.0 80.3
2 85 208.692; 208.232 206.362 85.0 85.1
3 90 219.393; 219.875 219.634 90.0 89.6
4 95 232.308; 231.809 232.059 95.0 94.7
5 100 245.641; 246.215 245.928 100.0 100.3
6 105 255.647; 256.133 255.890 105.0 104.4
7 110 269.383; 268.605 268.994 110.0 109.8
8 115 284.866; 284.915 284.891 115.0 116.2
9 120 296.371; 296.852 296.612 120.0 121.0
Weighed portion of the substance sodium hyaluronate, mg 90.5 mg
The content of the main substance in the sodium hyaluronate, % 99.4 %
Weight loss during drying of sodium hyaluronate, % 12.40 %
A graph of the dependence of the reduced area of the chromatographic peak on the reduced 
Si concentration is constructed for the analyte (Fig. 3). We visually evaluated the linearity of the 
obtained dependence, evaluate the compliance of the linear correlation coefficient Rc of the depen-
dence Yi (xi) with the criterion of acceptability.
For the linear dependence of the form Yi=a+b·xi, the parameters a and b are calculated by 
the method of least squares (MLC), guided by the article of the SPhU “Statistical analysis of the 
results of a chemical experiment”. The calculated basic indicators of linearity of the method are 
given in Table 6.
Compare the absolute value of the free term of the linear dependence with the calculated 
confidence interval Ga. The free member of the linear relationship should not exceed its confi-
dence interval.
For the linear dependence of the reduced area of the chromatographic peak on the reduced 
concentration of sodium hyaluronate |a|≤Δa (1.9490<2.56); Rc≥minRc (0.9991>0.9982). Therefore, 
the method is linear in the range of analyte concentration of 80–120 %.
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Fig. 3. Graph of the dependence of the reduced area of the chromatographic peak on the reduced 
concentration of sodium hyaluronate
Table 6
The results of determining the linearity of the method
Indicator Results
Free member of linear dependence |a| 1,9490




Fulfillment of the requirement |a|≤Δа The requirement is met
General correlation index Rc 0,9991
minRc 0,9981
Fulfillment of the requirement Rс≥minRc The requirement is met
Criteria of acceptability of control of correctness of a technique:
The correctness of the method characterizes the value of the systematic error δ, ie the devi-
ation of the mean value of the ratio found/entered from 100
The systematic error should be insignificant in comparison with the maximum allowable 




The results of determining the control of the correctness of the method are shown in Table 7.
As can be seen from the table, the value of the systematic error is equal to δ=0.12, which 
satisfies the condition δ≤0.51 %.
Acceptance criterion control of convergence of the method: the confidence interval of the 
unit value for the sample of relations found/entered must satisfy the condition Δz≤1.6 %.
When checking the convergence of the methods use the results obtained in determining 
its correctness. The calculations of the confidence interval of the unit value of the ratio were 
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value of the confidence interval Δz of the studied method of quantification satisfies the re-
quirements of Δz≤1.6 %.
Table 7
Results of determining the control of the correctness of the method
No. Sodium hyaluronate  content, %
Ratio found/entered,  
zі, %
The average value of the 
ratio found/entered, zі, %













The possibility and benefits of using the HPLC method for quantitative analysis of hyaluron-
ic acid and products of its metabolism have been confirmed by many researchers in the analysis 
of drugs, cosmetics and in determining the content of hyaluronic acid in biological fluids [16–18]. 
The chromatograms obtained by us are shown in Fig. 1, 2. The chromatograms shown in Fig. 1, 2 
indicate the possibility of identification and quantification of sodium hyaluronate in the combined 
gel by HPLC. The retention time of sodium hyaluronate in the test sample of the gel coincides with 
the peak and the retention time of the standard sample of the substance.
A common problem is the quantification of hyaluronic acid in combination drugs or dietary 
supplements [13, 14, 19]. Thus, oral drugs that can nourish bones and joints contain macromolecu-
lar compounds such as hyaluronic acid, methylsulfonylmethane (MSM), chondroitin, glucosamine 
and collagen. For quantitative analysis of a mixture of hyaluronic acid and methylsulfonylmethane, 
derivatization of hyaluronic acid using fluorenylmethyloxycarbonyl chloride is used, followed by 
analysis by liquid chromatography with fluorescence detection. The developed method was linear 
(r=0.9983) in the range of 5–50 ppm, and the limits of detection and quantification were 3.55 and 
11.84 ppm, respectively [19]. Due to the absence of UV-absorbing chromophore in the structure of 
hyaluronic acid, its quantitative analysis in the presence of excipients of highly polar nature (so-
dium phosphate, phosphoric acid, potassium hydroxide, etc.) is quite problematic. The solution to 
the problem was a new method for the determination of sodium hyaluronate based on liquid chro-
matography using a UV detector with a variable wavelength set at 205 nm. Specificity/selectivity 
experiments revealed the absence of interference from excipients, recovery from spiked samples 
for sodium hyaluronate was 99–102 [14].
The method developed by us allows to quantify sodium hyaluronate in the presence of 
other active substances (metronidazole benzoate, miramistin) and excipients (carbomer, sodium 
hydroxide, etc.). The validation of the developed analytical methodology confirms its specificity 
and reproducibility. Specificity/selectivity experiments revealed the absence of interference from 
excipients, recovery from spiked samples for sodium hyaluronate was 99.4–101.07. The validation 
characteristics of the developed methodology must meet the established eligibility criteria [15, 20]. 
The spectral purity coefficients (Fp) of the sodium hyaluronate peak on the chromatograms of 
the model solution are Fp1=997,665 and Fp2=997,802. The obtained values meet the acceptability 
criterion Fp≥995.0 and significantly exceed the critical value. The method is linear in the range 
of sodium concentration of hyaluronate 80–120 %, the calculated linear dependence of the re-
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duced area of the chromatographic peak on the reduced concentration of sodium hyaluronate is 
|a|=1.9490≤Δa=2.56. The calculated systematic error (δ) and the confidence interval (Δz) meet 
the eligibility criteria and confirm the correctness and convergence of the developed method of 
quantification.
Study limitations. The chromatogram of the test gel solution (Fig. 2), in addition to the 
peak of sodium hyaluronate, contains peaks of response of other substances. We did not identify 
these substances within the studies. The main criterion was the conformity of the retention time of 
sodium hyaluronate to the standard sample solution and the absence of the effect of unidentified 
substances on the accuracy of measurement.
Prospects for further research. Conducting research to study the stability of the developed 
combined gel, determining the effect of storage conditions, container material on the chemical 
stability of active substances, in particular sodium hyaluronate. 
5. Conclusions
1. A method for the identification and quantification of sodium hyaluronate by HPLC using 
a PL-aquagel-OH, Agilent chromatographic column with a size of 300×7.5 mm and detection at a 
wavelength of 210 nm. The retention time of sodium hyaluronate is about 5.02 min with a symme-
try factor of 1.29.
2. The method allows for qualitative and quantitative analysis of sodium hyaluronate in the 
combined gel, in the presence of other active substances (metronidazole benzoate, miramistin).
3. The main validation characteristics of the method of quantitative determination of sodi-
um hyaluronate by HPLC are determined. In terms of specificity, linearity, correctness, conver-
gence, the developed methodology meets the criteria of SPhU acceptability.
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